What is it about?
The study compares the use of two different antibodies to detect FXR1 protein in the canine species, and then depict the immunohistochemical distribution of FXR1 in normal canine tissues and in a pool of canine melanocytic tumors.
Featured Image
Why is it important?
Anti-FXR1 antibodies are validated for the first time for the use in the canine species. FXR1 distribution in normal tissues of dogs is described in detail.
Read the Original
This page is a summary of: Immunohistochemical Expression of FXR1 in Canine Normal Tissues and Melanomas, Journal of Histochemistry & Cytochemistry, April 2018, SAGE Publications,
DOI: 10.1369/0022155418766292.
You can read the full text:
Contributors
The following have contributed to this page
